During the past decade, Altoona Center For Clinical Research conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 140 clinical trials were completed, i.e. on average, 99.3% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 75 clinical trials were completed. i.e. 141.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altoona Center For Clinical Research" #1 sponsor was "Pfizer" with 48 trials, followed by "Eli Lilly and Company" with 26 trials sponsored, "Bristol-Myers Squibb" with 17 trials sponsored, "Amgen" with 9 trials sponsored and "Hoffmann-La Roche" with 9 trials sponsored. Other sponsors include 191 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altoona Center For Clinical Research" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator, "Galapagos NV" with 3 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Medpace, Inc." with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Altoona Center For Clinical Research" are "Rheumatoid Arthritis" (81 trials), "Osteoarthritis" (29 trials), "Gout" (13 trials), "Arthritis, Rheumatoid" (12 trials) and "Osteoarthritis, Knee" (12 trials). Many other conditions were trialed in "Altoona Center For Clinical Research" in a lesser frequency.

Most popular intervention types in "Altoona Center For Clinical Research" are "Drug" (250 trials), "Biological" (53 trials), "Other" (34 trials), "Device" (11 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (124 trials), "Methotrexate" (15 trials), "placebo" (13 trials), "Abatacept" (9 trials) and "Adalimumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Altoona Center For Clinical Research" are 295 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Altoona Center For Clinical Research". undefined are not yet recruiting, 15 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 232 completed trials in Altoona Center For Clinical Research, undefined suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Altoona Center For Clinical Research, 34 "Phase 1" clinical trials were conducted, 119 "Phase 2" clinical trials and 118 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 5 trials that are defined as “Not Applicable".